Literature DB >> 19142901

Lymph nodes and gastric cancer.

Natalie G Coburn1.   

Abstract

Worldwide, gastric cancer is one of the top three leading causes of cancer mortality, but incidence and presentation vary geographically. Currently, surgery is the only possible cure. Nodal status is an important prognostic indicator for gastric cancer, and despite results of randomized controlled trials, debate continues over the importance of aggressive lymphadenectomy.

Entities:  

Mesh：

Year:  2009        PMID： 19142901     DOI： 10.1002/jso.21224

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  34 in total

Review 1.  Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature.

Authors:  Yves Dittmar; Falk Rauchfuss; Max Goetz; Karin Jandt; Hubert Scheuerlein; Michael Heise; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2012-02-04       Impact factor: 3.445

2.  MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.

Authors:  Ruixin Li; Weijie Yuan; Wenjuan Mei; Keda Yang; Zihua Chen
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

3.  CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.

Authors:  X G Zhang; B T Song; F J Liu; D Sun; K X Wang; H Qu
Journal:  Clin Transl Oncol       Date:  2015-10-21       Impact factor: 3.405

4.  miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer.

Authors:  Zhiqin Tan; Hao Jiang; Youhua Wu; Liming Xie; Wenxiang Dai; Hailin Tang; Sanyuan Tang
Journal:  Mol Cell Biochem       Date:  2013-10-25       Impact factor: 3.396

5.  Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer.

Authors:  Yves Dittmar; Falk Rauchfuss; Max Götz; Hubert Scheuerlein; Karin Jandt; Utz Settmacher
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

6.  [miR-449a/b negatively regulates E2F1 to suppress proliferation of gastric cancer cells].

Authors:  Aiqin Lin; Wenjie Bu; Ping Wang; Jiguang Gao; Jianke Yang; Feiyu Ding; Tiechen Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

7.  Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

Authors:  Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

8.  Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer: technical notes.

Authors:  Elena Orsenigo; Saverio Di Palo; Edi Viale; Enzo Masci; Carla Canevari; Luigi Gianolli; Carlo Staudacher
Journal:  Surg Endosc       Date:  2010-02-26       Impact factor: 4.584

9.  Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes.

Authors:  Iain G Thomson; David C Gotley; Andrew P Barbour; Ian Martin; Neil Jayasuria; Janine Thomas; Bernard M Smithers
Journal:  Gastric Cancer       Date:  2013-03-09       Impact factor: 7.370

Review 10.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.